Stay updated on APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The record history page’s revision/version label has been updated from v3.5.2 to v3.5.3, indicating a site/version change rather than a modification to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:47:24.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 to the history. Removed Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T02:36:51.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 in the record history. Removed Revision: v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-19T05:15:49.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    New revision entry v3.4.3 was added to the history, replacing the previous v3.4.2 entry. It reflects a site version update and does not modify trial data or the study record.
    Difference
    0.1%
    Check dated 2026-03-12T01:03:46.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and older items (a funding notice and v3.4.1) were removed. These are administrative updates to the page’s revision history rather than to study data or core content.
    Difference
    0.5%
    Check dated 2026-02-11T14:15:21.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page adds a government funding notice banner and updates the revision from v3.4.0 to v3.4.1, which affects only site-wide notices and versioning rather than core trial data; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:21:49.000Z thumbnail image

Stay in the know with updates to APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.